J. Bojadzieva's Profile

Role	Title	Level	Year	L/R
🐜	Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis 36 auth. M. Ballinger, A. Best, P. Mai, Payal P. Khincha, J. Loud, June A Peters, M. Achatz, R. Chojniak, Alexandre Balieiro da Costa, Karina Miranda Santiago, J. Garber, Allison F. O’Neill, R. Eeles, D. G. Evans, E. Bleiker, ... G. Sonke, M. Ruijs, C. Loo, J. Schiffman, Anne Naumer, W. Kohlmann, L. Strong, J. Bojadzieva, D. Malkin, S. Rednam, E. Stoffel, E. Koeppe, J. Weitzel, T. Slavin, Bita Nehoray, M. Robson, M. Walsh, L. Manelli, A. Villani, David M. Thomas, S. Savage	7	2017	7 🐜
🐜	Early onset HER2‐positive breast cancer is associated with germline TP53 mutations 11 auth. A. Melhem-Bertrandt, J. Bojadzieva, K. Ready, E. Obeid, Diane D. Liu, A. Gutierrez-Barrera, ... J. Litton, O. Olopade, G. Hortobagyi, L. Strong, B. Arun	7	2012	7 🐜
🐜	Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants. 216 auth. A. Bournazos, L. Riley, Shobhana Bommireddipalli, L. Adès, Lauren S. Akesson, M. Al-shinnag, Stephen I. Alexander, A. Archibald, S. Balasubramaniam, Y. Berman, V. Beshay, Kirsten Boggs, J. Bojadzieva, N. Brown, S. Bryen, ... M. Buckley, B. Chong, M. Davis, R. Dawes, M. Delatycki, Liz Donaldson, Lilian Downie, Caitlin Edwards, M. Edwards, Amanda Engel, Lisa J Ewans, Fathimath Faiz, A. Fennell, M. Field, M. Freckmann, L. Gallacher, Russell Gear, H. Goel, Shuxiang Goh, L. Goodwin, B. Hanna, J. Harraway, Megan E. Higgins, G. Ho, Bruce Hopper, A. Horton, M. Hunter, A. Huq, S. Josephi-Taylor, H. Joshi, E. Kirk, Emma I. Krzesinski, K. Kumar, F. Lemckert, R. Leventer, S. Lindsey-Temple, S. Lunke, A. Ma, S. Macaskill, A. Mallawaarachchi, M. Marty, J. Marum, H. McCarthy, M. Menezes, Alison McLean, D. Milnes, S. Mohammad, D. Mowat, A. Niaz, E. Palmer, C. Patel, Shilpan G. Patel, D. Phelan, J. Pinner, S. Rajagopalan, M. Regan, Jonathan Rodgers, Miriam J. Rodrigues, R. Roxburgh, R. Sachdev, T. Roscioli, Ruvishani Samarasekera, S. Sandaradura, E. Savva, Timo Schindler, Margi Shah, I. Sinnerbrink, Janine M. Smith, Richard Smith, A. Springer, Zornitza Stark, Samuel P. Strom, C. Sue, Kenneth Tan, T. Tan, E. Tantsis, M. Tchan, B. Thompson, A. Trainer, Karin van Spaendonck-Zwarts, Rebecca C. Walsh, L. Warwick, Stephanie L. White, S. White, Mark Williams, Meredith Wilson, W. Wong, D. Wright, Patrick Yap, A. Yeung, H. Young, K. Jones, B. Bennetts, Sandra T. Cooper, Ghusoon Abdulrasool, Ghamdan Al Eryani, P. Arts, R. Bagnall, Naomi L. Baker, Christopher Barnett, S. Beecroft, M. Berbic, Michaela Black, J. Blackburn, P. Blombery, S. Branford, J. Breen, L. Burnett, D. Canson, P. Cheong, E. Chew, J. Christodoulou, S. Chung, Mike Clark, C. Cliffe, Melissa K Cole, F. Collins, A. Compton, A. Cooper, M. Corbett, M. Cowley, T. Dudding, Stefanie Eggers, E. Eyras, Miriam Fanjul Fernández, A. Fellowes, R. Fleischer, C. Folland, L. Fox, C. Gaff, Melanie A. Galea, R. Ghaoui, Ilias Gornanitis, Thuong T. Ha, R. Hayashi, I. Hayes, A. Henderson, L. Hesson, Erin E. Heyer, Michael Hildebrand, M. Hipwell, C. Hoskins, Matilda R Jackson, Paul James, J. Wong, K. Kassahn, P. Kaub, L. Kevin, Smitha Kumble, S. Kummerfeld, N. Laing, C. Lau, Eric Lee, Sarah Leighton, Ben Lundie, Chelsea Mayoh, J. McGaughran, M. McPhillips, C. Meldrum, E. Middleton, K. Mina, A. Nisselle, E. Oates, A. Oshlack, G. Parasivam, M. Parsons, M. Quinn, J. Rasko, G. Ravenscroft, A. Ravine, Krista Recsei, J. Rehn, S. Robertson, A. Ronan, G. Ryland, S. Sadedin, A. Schreiber, Hamish Scott, R. Scott, C. Semsarian, Cas Simons, E. Singer, Renée Smyth, A. Spurdle, Patricia Sullivan, S. Sundercombe, D. Thorburn, J. Toubia, R. Trent, Emma Tudini, Irina Voneague, L. Waddell, L. Walker, M. Wallis, N. Warnock, Robert J. Weatheritt, D. White, I. Winship, L. Worgan, Kathy Wu, A. Ziolowski	5	2021	5 🐜
🦁	Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic 10 auth. J. Bojadzieva, B. Amini, Suzanne F. Day, T. Jackson, Parijatham S. Thomas, Brandy J. Willis, ... Whitney R. Throckmorton, N. Daw, T. Bevers, L. Strong	5	2017	5 🦁
🐜	The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome 7 auth. J. Ross, J. Bojadzieva, S. Peterson, S. Noblin, Rebecca Yzquierdo, Martha A Askins, ... L. Strong	5	2017	5 🐜
🐜	Penetrance of different cancer types in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts. 15 auth. S. Shin, E. Dodd-Eaton, G. Peng, J. Bojadzieva, Jingxiao Chen, C. Amos, Megan N. Frone, Payal P. Khincha, P. Mai, S. Savage, ... M. Ballinger, David M. Thomas, Ying Yuan, L. Strong, Wenyi Wang	4	2019	4 🐜
🐜	Estimating TP53 Mutation Carrier Probability in Families with Li–Fraumeni Syndrome Using LFSPRO 10 auth. G. Peng, J. Bojadzieva, M. Ballinger, Jialu Li, A. Blackford, P. Mai, ... S. Savage, David M. Thomas, L. Strong, Wenyi Wang	4	2017	4 🐜
🐬	Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome S. Shin, Ying Yuan, L. Strong, J. Bojadzieva, Wenyi Wang	3	2017	3 🐬